Your shopping cart is currently empty.
- CRISPR-Cas9
- Cell Culture and Transfection Reagents
- EliteTrust Human Gene ORF Virus Particle Collection
- Featured Products
- Lentiviral Cloning Vectors
- Lentivirus Concentration and Purification kit
- Lentivirus Freeze-Thaw Protection Medium
- Lentivirus Packaging System
- Lentivirus Titration
- Premade Lentivirus
- Premade Stable Cell Line
- Stem Cell Research
- Vectors for iPS Cells Generation
- xpath of 1st category mapping
- xpath of 2nd category mapping
- DNA Mutagenesis
- EliteTrust Cell Authentication Service
- EliteTrust Custom Adeno-Associated Virus Production
- EliteTrust Custom Gene Targeting Service
- EliteTrust Custom Lentivirus Production
- EliteTrust Custom Retrovirus Production Service
- EliteTrust Custom Stable Cell Line Generation Service
- EliteTrust Stable Cell Line Mycoplasma Detection Service
Preclinical Lentivirus Production
CAR-T lentivirus for Preclinical Development
Adoptive transfer of T cells expressing chimeric antigen receptors (CAR-T) is a promising anti-cancer immunotherapeutic strategy. Large quantity of high quality lentivirus is required to genetically engineer large number of a patient's T cells to express CARs, specifically directed towards antigens on tumor cells.
With the cutting-edge lentivirus production platform, Cellomics Technology has been routinely providing Custom Preclinical Grade Lentivirus Production Service for preclinical development of CAR-T immunotherapy.
Though the lentiviruses are produced for preclinical development, the same procedure to produce the clinical trial grade lentivirus is followed . Our Custom Preclinical Grade of Lentivirus Production Service meets our customers’ need satisfactorily for preclinical development, providing quick track to translate innovative CAR-T discoveries from laboratory to clinical trial.
Advantages
• Cost-effective
• Quick turnaround: 1-2 weeks
• High titer, high purity, serum-free
• Fast track for translating your research discovery to clinical trial
Adoptive transfer of T cells expressing chimeric antigen receptors (CAR-T) is a promising anti-cancer immunotherapeutic strategy. Large quantity of high quality lentivirus is required to genetically engineer large number of a patient's T cells to express CARs, specifically directed towards antigens on tumor cells.
With the cutting-edge lentivirus production platform, Cellomics Technology has been routinely providing Custom Preclinical Grade Lentivirus Production Service for preclinical development of CAR-T immunotherapy.
Though the lentiviruses are produced for preclinical development, the same procedure to produce the clinical trial grade lentivirus is followed . Our Custom Preclinical Grade of Lentivirus Production Service meets our customers’ need satisfactorily for preclinical development, providing quick track to translate innovative CAR-T discoveries from laboratory to clinical trial.
Advantages
• Cost-effective
• Quick turnaround: 1-2 weeks
• High titer, high purity, serum-free
• Fast track for translating your research discovery to clinical trial